Israel Active

Israeli-founded startup Zone7 (InPlay Ltd) has developed software that analyzes data from wearables and video, tracks medical condition and performance and forecasts injuries. It is used by soccer clubs in the UK, Israel, and Spain. Zone7 has just raised $2.5 million including from top sportsmen.

A 7-year international study led by Tel Aviv Sourasky (Ichilov) Medical Center’s Professor Eli Sprecher, has revealed that a defect in the protein gene PAD13 is responsible for hair loss due to Central Centrifugal Cicatricial Alopecia [CCCA]. The condition affects 5% of African-American women.

I reported previously on Israel’s DreaMed Diabetes monitors. DreaMed has just partnered with French company BioCorp to create an Artificially Intelligent system that integrates BioCorp’s Mallya smart cap for pen injectors with DreaMed’s Advisor Pro insulin analysis system.

Israel’s Technion has partnered with Israeli startup Cordio Medical to develop a smartphone app to identify the first signs of heart failure. The app detects changes in a person’s voice due to lung fluid - an early warning of congestive heart failure. Clinical trials are in progress.

A patient, with Buerger’s disease was at pre-amputation stage due to non-healing foot ulcers. Regulatory approval was given for compassionate treatment using Pluristem’s PLX-PAD cells. A year after treatment, the wound is fully closed, and the patient has resumed normal activities.

I reported briefly previously that Israel’s KidneyCure was developing cell therapy for treating chronic kidney disease (CKD). Here are some more details of this innovative technology that turns damaged cells into healthy cells.

I reported previously on Israel’s Eximo and its lasers for treating peripheral artery disease (PAD). The Center for Cardiovascular Excellence in Orlando, Florida is the first to use Eximo’s B-Laser Atherectomy System commercially to successfully treat a patient.

Tel Aviv’s Sourasky (Ichilov) Hospital and Israel’s largest health companies Clalit and Maccabi will use the algorithms of Israel’s Zebra Medical Vision to analyze scanned images from X-rays, CT scans and MRIs.

I reported previously on Israel’s Omeq Medical and its smart sensor-based epidural injection system.  Omeq has partnered with Shanghai-based Pharos Medical, which will establish a production line and commercialize Omeq’s system in China.

Researchers from Israel’s Technion Institute have devised a system for measuring the effectiveness of a combination of antibiotics in fighting infection.